Help the Brain Aneurysm Foundation be the 2019 Charity Warriors Challenge Champion. The challenge is a team-based fundraising competition. Women leaders of MA-based nonprofits will lead co-ed teams to raise funds and awareness for their causes while competing to win an invitation to a pitch event, and $10,000.
The competition consists of four weeks of fundraising May 8 - June 4.
We have entered this year's Warrior Challenge to help increase revenue for mission critical education and research.
The Brain Aneurysm Foundation is the globally recognized leader in brain aneurysm awareness, education, support, advocacy and research funding. The foundation’s mission is to provide information about and raise awareness of the symptoms and risk factors of brain aneurysms to prevent ruptures and subsequent death and disability; work with medical communities to provide support networks for patients and families; and advance research to improve patients’ outcomes and save lives.
The foundation is trying to raise the level of awareness of brain aneurysms in both the general public and medical communities. People need to be aware of the signs and symptoms, and medical professionals need to include brain aneurysms in their differential diagnosis. The federal government only spends 83 cents per year per person affected by a brain aneurysm, which is extremely low in comparison to diseases with a similar prevalence. Currently the BAF is the largest private funder of brain aneurysm research but it is not enough. Brain aneurysms are treatable and beatable, but early detection is key for best outcomes and to save lives.
Christine Buckley, Executive Director ~ “Working for the Brain Aneurysm Foundation is an honor and has become a passion. To go to work every day and have the chance to help someone, as well as to go home at the end of the day knowing I was able to help someone is simply amazing. Because there is still so much to be done for brain aneurysm patients and among the scientific community, each day presents unique challenges and opportunities that ultimately lead to incredible strides for the disease.”